Stuart J Swiedler, MD, Ph.D.
Rare Disease / Clinical Research
BioMarin Pharmaceutical
QC-verified· March 2026 PI on 1 trial
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing dataRare diseases treated or studied
Based on trial PI assignments and publication topics.
Clinical trials (1)
Verify independently
Other specialists for Mucopolysaccharidosis type 6
Peers ranked by clinical-trial PI role, publications, and verification quality.
- Stuart J Sweidler, MD, Ph.D.BioMarin Pharmaceutical
- Thierry BILLETTE DE VILLEMEURINSERM UMR 1141
- Paul Orchard, MD, MDUniversity of Minnesota Medical CenterMN
- Tippi C MacKenzie, MDUniversity of California, San FranciscoCalifornia
- Mitchell S Cairo, MD, MDNew York Medical CollegeNY
- Paul Orchard, M.D., MDMasonic Cancer Center, University of MinnesotaMN
- Lynda E Polgreen, MD, MS, MDLos Angeles BioMedical Research Center at Harbor-UCLACA
- Tippi MacKenzie, MDUniversity of California, San FranciscoCalifornia